Inventor
SHACHAM SHARON
US51 patents
⚠️ This page may combine multiple inventors who share the name “SHACHAM SHARON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KARYOPHARM THERAPEUTICS INC
26 patentsUS9861614B2Jan 9, 2018
Nuclear transport modulators and uses thereof
KARYOPHARM THERAPEUTICS INC27 citations98
US9714226B2Jul 25, 2017
Hydrazide containing nuclear transport modulators and uses thereof
KARYOPHARM THERAPEUTICS INC28 citations98
US9585874B2Mar 7, 2017
Nuclear transport modulators and uses thereof
KARYOPHARM THERAPEUTICS INC27 citations98
US9266843B2Feb 23, 2016
Nuclear transport modulators and uses thereof
KARYOPHARM THERAPEUTICS INC31 citations98
US9206158B2Dec 8, 2015
Hydrazide containing nuclear transport modulators and uses thereof
KARYOPHARM THERAPEUTICS INC28 citations98
US9096543B2Aug 4, 2015
Nuclear transport modulators and uses thereof
KARYOPHARM THERAPEUTICS INC35 citations98
US8999996B2Apr 7, 2015
Hydrazide containing nuclear transport modulators and uses thereof
KARYOPHARM THERAPEUTICS INC44 citations98
US9738624B2Aug 22, 2017
Nuclear transport modulators and uses thereof
KARYOPHARM THERAPEUTICS INC29 citations97
US11034660B2Jun 15, 2021
Hydrazide containing nuclear transport modulators and uses thereof
KARYOPHARM THERAPEUTICS INC10 citations94
US10544108B2Jan 28, 2020
Hydrazide containing nuclear transport modulators and uses thereof
KARYOPHARM THERAPEUTICS INC14 citations94
US10173987B2Jan 8, 2019
Hydrazide containing nuclear transport modulators and uses thereof
KARYOPHARM THERAPEUTICS INC18 citations94
US11124493B2Sep 21, 2021
Nuclear transport modulators and uses thereof
KARYOPHARM THERAPEUTICS INC12 citations93
US10407405B2Sep 10, 2019
Nuclear transport modulators and uses thereof
KARYOPHARM THERAPEUTICS INC21 citations93
US9550757B2Jan 24, 2017
Nuclear transport modulators and uses thereof
KARYOPHARM THERAPEUTICS INC24 citations93
US11787771B2Oct 17, 2023
Hydrazide containing nuclear transport modulators and uses thereof
KARYOPHARM THERAPEUTICS INC5 citations86
US11945794B2Apr 2, 2024
Nuclear transport modulators and uses thereof
KARYOPHARM THERAPEUTICS INC4 citations85
US10399963B2Sep 3, 2019
Substituted benzofuranyl and benzoxazolyl compounds and uses thereof
KARYOPHARM THERAPEUTICS INC5 citations83
US10202366B2Feb 12, 2019
Methods of promoting wound healing using CRM1 inhibitors
KARYOPHARM THERAPEUTICS INC22 citations83
US9856241B2Jan 2, 2018
Substituted benzofuranyl and benzoxazolyl compounds and uses thereof
KARYOPHARM THERAPEUTICS INC8 citations83
US12291508B2May 6, 2025
Hydrazide containing nuclear transport modulators and uses thereof
KARYOPHARM THERAPEUTICS INC2 citations75
US10363247B2Jul 30, 2019
(S,E)-3-(6-aminopyridin-3-yl)-N-((5-(4-(3-fluoro-3-methylpyrrolidine-1-carbonyl)phenyl-7-(4-fluorophenyl)benzofuran-2-yl)methyl)acrylamide for the treatment of cancer
KARYOPHARM THERAPEUTICS INC5 citations73
US9938258B2Apr 10, 2018
Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof
KARYOPHARM THERAPEUTICS INC6 citations73
US11008309B2May 18, 2021
Substituted benzofuranyl and benzoxazolyl compounds and uses thereof
KARYOPHARM THERAPEUTICS INC2 citations72
US9994558B2Jun 12, 2018
Multicyclic compounds and methods of using same
KARYOPHARM THERAPEUTICS INC6 citations72
US12577225B2Mar 17, 2026
Nuclear transport modulators and uses thereof
KARYOPHARM THERAPEUTICS INC0 citations62
US12331040B2Jun 17, 2025
Substituted benzofuranyl and benzoxazolyl compounds and uses thereof
KARYOPHARM THERAPEUTICS INC0 citations62
EPIX DELAWARE INC
7 patentsUS7488736B2Feb 10, 2009
Thienopyridinone compounds and methods of treatment
EPIX DELAWARE INC11 citations82
US7407966B2Aug 5, 2008
Thienopyridinone compounds and methods of treatment
EPIX DELAWARE INC12 citations82
US7598265B2Oct 6, 2009
Compositions and methods for treating CNS disorders
EPIX DELAWARE INC7 citations72
US7576211B2Aug 18, 2009
Synthesis of thienopyridinone compounds and related intermediates
EPIX DELAWARE INC5 citations61
US7491727B2Feb 17, 2009
Arylpiperazinyl compounds
EPIX DELAWARE INC1 citations61
US7488731B2Feb 10, 2009
Arylpiperazinyl compounds
EPIX DELAWARE INC3 citations61
US7612078B2Nov 3, 2009
Piperidinylamino-thieno[2,3-D] pyrimidine compounds
EPIX DELAWARE INC2 citations60
BIOGEN MA INC
6 patentsUS10058535B2Aug 28, 2018
Nuclear transport modulators and uses thereof
BIOGEN MA INC24 citations98
US10335393B2Jul 2, 2019
Nuclear transport modulators and uses thereof
BIOGEN MA INC20 citations94
US10722497B2Jul 28, 2020
Nuclear transport modulators and uses thereof
BIOGEN MA INC3 citations84
US10617677B2Apr 14, 2020
Nuclear transport modulators and uses thereof
BIOGEN MA INC3 citations84
US10925859B2Feb 23, 2021
Nuclear transport modulators and uses thereof
BIOGEN MA INC1 citations73
US11318120B2May 3, 2022
Nuclear transport modulators and uses thereof
BIOGEN MA INC0 citations62
SANDANAYAKA VINCENT P
3 patentsUS9079865B2Jul 14, 2015
Hydrazide containing nuclear transport modulators and uses thereof
SANDANAYAKA VINCENT P38 citations97
US9303000B2Apr 5, 2016
Olefin containing nuclear transport modulators and uses thereof
SANDANAYAKA VINCENT P28 citations93
US9428490B2Aug 30, 2016
Nuclear transport modulators and uses thereof
SANDANAYAKA VINCENT P27 citations91
EPIX PHARM INC
2 patentsSHACHAM SHARON
1 patentGALENEA CORP
1 patentNANOTHERAPEUTICS INC
1 patentBEN-ZEEV EFRAT
1 patentBECKER OREN
1 patentMICRODOSE THERAPEUTX INC
1 patentShowing the top 50 of 51 patents by PatentIndex Score.